124 related articles for article (PubMed ID: 35266828)
1. Impact of Short-Term Storage on
Okitwi M; Orena S; Thomas K; Tumwebaze PK; Byaruhanga O; Nsobya SL; Conrad MD; Bayles BR; Rosenthal PJ; Cooper RA
Antimicrob Agents Chemother; 2022 Apr; 66(4):e0143721. PubMed ID: 35266828
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline.
Kreutzfeld O; Tumwebaze PK; Okitwi M; Orena S; Byaruhanga O; Katairo T; Conrad MD; Rasmussen SA; Legac J; Aydemir O; Giesbrecht D; Forte B; Campbell P; Smith A; Kano H; Nsobya SL; Blasco B; Duffey M; Bailey JA; Cooper RA; Rosenthal PJ
Microbiol Spectr; 2023 Jun; 11(3):e0523622. PubMed ID: 37158739
[TBL] [Abstract][Full Text] [Related]
3. Associations between Varied Susceptibilities to PfATP4 Inhibitors and Genotypes in Ugandan Plasmodium falciparum Isolates.
Kreutzfeld O; Rasmussen SA; Ramanathan AA; Tumwebaze PK; Byaruhanga O; Katairo T; Asua V; Okitwi M; Orena S; Legac J; Conrad MD; Nsobya SL; Aydemir O; Bailey J; Duffey M; Bayles BR; Vaidya AB; Cooper RA; Rosenthal PJ
Antimicrob Agents Chemother; 2021 Sep; 65(10):e0077121. PubMed ID: 34339273
[TBL] [Abstract][Full Text] [Related]
4. Susceptibilities of Ugandan Plasmodium falciparum Isolates to Proteasome Inhibitors.
Garg S; Kreutzfeld O; Chelebieva S; Tumwebaze PK; Byaruhanga O; Okitwi M; Orena S; Katairo T; Nsobya SL; Conrad MD; Aydemir O; Legac J; Gould AE; Bayles BR; Bailey JA; Duffey M; Lin G; Kirkman LA; Cooper RA; Rosenthal PJ
Antimicrob Agents Chemother; 2022 Oct; 66(10):e0081722. PubMed ID: 36094216
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo responses of Plasmodium falciparum clinical isolates to conventional and new antimalarial drugs in Niger.
Issaka M; Salissou A; Arzika I; Guillebaud J; Maazou A; Specht S; Zamanka H; Fandeur T
Antimicrob Agents Chemother; 2013 Jul; 57(7):3415-9. PubMed ID: 23612203
[TBL] [Abstract][Full Text] [Related]
6. Drug susceptibility of
Tumwebaze PK; Katairo T; Okitwi M; Byaruhanga O; Orena S; Asua V; Duvalsaint M; Legac J; Chelebieva S; Ceja FG; Rasmussen SA; Conrad MD; Nsobya SL; Aydemir O; Bailey JA; Bayles BR; Rosenthal PJ; Cooper RA
Lancet Microbe; 2021 Sep; 2(9):e441-e449. PubMed ID: 34553183
[TBL] [Abstract][Full Text] [Related]
7. Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil.
Aguiar AC; Pereira DB; Amaral NS; De Marco L; Krettli AU
Malar J; 2014 Feb; 13():73. PubMed ID: 24581308
[TBL] [Abstract][Full Text] [Related]
8. Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance.
Chaorattanakawee S; Saunders DL; Sea D; Chanarat N; Yingyuen K; Sundrakes S; Saingam P; Buathong N; Sriwichai S; Chann S; Se Y; Yom Y; Heng TK; Kong N; Kuntawunginn W; Tangthongchaiwiriya K; Jacob C; Takala-Harrison S; Plowe C; Lin JT; Chuor CM; Prom S; Tyner SD; Gosi P; Teja-Isavadharm P; Lon C; Lanteri CA
Antimicrob Agents Chemother; 2015 Aug; 59(8):4631-43. PubMed ID: 26014942
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina Faso.
Tahita MC; Tinto H; Yarga S; Kazienga A; Traore Coulibaly M; Valea I; Van Overmeir C; Rosanas-Urgell A; Ouedraogo JB; Guiguemde RT; van Geertruyden JP; Erhart A; D'Alessandro U
Malar J; 2015 Jun; 14():251. PubMed ID: 26088768
[TBL] [Abstract][Full Text] [Related]
10. State of Artemisinin and Partner Drug Susceptibility in
Montenegro LM; de Las Salas B; Neal AT; Tobon-Castaño A; Fairhurst RM; Lopera-Mesa TM
Am J Trop Med Hyg; 2021 Jan; 104(1):263-270. PubMed ID: 33289466
[TBL] [Abstract][Full Text] [Related]
11. Changing Antimalarial Drug Sensitivities in Uganda.
Rasmussen SA; Ceja FG; Conrad MD; Tumwebaze PK; Byaruhanga O; Katairo T; Nsobya SL; Rosenthal PJ; Cooper RA
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923866
[TBL] [Abstract][Full Text] [Related]
12. [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
Touré AO; Koné LP; Jambou R; Konan TD; Demba S; Beugre GE; Koné M
Sante; 2008; 18(1):43-7. PubMed ID: 18684691
[TBL] [Abstract][Full Text] [Related]
13. Direct comparison of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR green I fluorescence (MSF) drug sensitivity tests in Plasmodium falciparum reference clones and fresh ex vivo field isolates from Cambodia.
Chaorattanakawee S; Tyner SD; Lon C; Yingyuen K; Ruttvisutinunt W; Sundrakes S; Sai-gnam P; Johnson JD; Walsh DS; Saunders DL; Lanteri CA
Malar J; 2013 Jul; 12():239. PubMed ID: 23849006
[TBL] [Abstract][Full Text] [Related]
14. In vivo sensitivity of Plasmodium falciparum to chloroquine, amodiaquine and sulfadoxine-pyrimethamine in western Uganda.
Kamugisha J; Kipp W; Burnham G
Trop Geogr Med; 1994; 46(6):364-5. PubMed ID: 7892705
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the drug susceptibility of Plasmodium falciparum clinical isolates from africa by using a Plasmodium lactate dehydrogenase immunodetection assay and an inhibitory maximum effect model for precise measurement of the 50-percent inhibitory concentration.
Kaddouri H; Nakache S; Houzé S; Mentré F; Le Bras J
Antimicrob Agents Chemother; 2006 Oct; 50(10):3343-9. PubMed ID: 17005815
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium falciparum In Vitro Resistance to Monodesethylamodiaquine, Dakar, Senegal, 2014.
Fall B; Madamet M; Camara C; Amalvict R; Fall M; Nakoulima A; Diatta B; Diémé Y; Wade B; Pradines B
Emerg Infect Dis; 2016 May; 22(5):841-5. PubMed ID: 27088703
[TBL] [Abstract][Full Text] [Related]
17. Associations between Malaria-Preventive Regimens and Plasmodium falciparum Drug Resistance-Mediating Polymorphisms in Ugandan Pregnant Women.
Nayebare P; Asua V; Conrad MD; Kajubi R; Kakuru A; Nankabirwa JI; Muhanguzi D; Dorsey G; Kamya MR; Nsobya S; Rosenthal PJ
Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 33020152
[TBL] [Abstract][Full Text] [Related]
18. Molecular identification and anti-malarial drug resistance profile of Plasmodium falciparum from patients attending Kisoro Hospital, southwestern Uganda.
Manirakiza G; Kassaza K; Taremwa IM; Bazira J; Byarugaba F
Malar J; 2022 Jan; 21(1):21. PubMed ID: 35033082
[TBL] [Abstract][Full Text] [Related]
19.
Agarwal P; Anvikar AR; Pillai CR; Srivastava K
Indian J Med Res; 2017 Nov; 146(5):622-628. PubMed ID: 29512604
[TBL] [Abstract][Full Text] [Related]
20. THE EFFICACY OF MARINE NATURAL PRODUCTS AGAINST PLASMODIUM FALCIPARUM.
Goto Y; Kamihira R; Nakao Y; Nonaka M; Takano R; Xuan X; Kato K
J Parasitol; 2021 Mar; 107(2):284-288. PubMed ID: 33844839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
